| Trial ID: | L4564 |
| Source ID: | NCT01155518
|
| Associated Drug: |
Testosterone
|
| Title: |
Hypogonadism in Young Men With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01155518/results
|
| Conditions: |
Hypogonadotropic Hypogonadism|Type 2 Diabetes
|
| Interventions: |
DRUG: testosterone|DRUG: clomiphene|DRUG: placebo|DRUG: placebo
|
| Outcome Measures: |
Primary: Insulin Resistance, To compare the insulin sensitivity as measured by whole body glucose uptake during hyperinsulinemic euglycemic (HE) clamp in young T2D men with and without HH., 6 months |
|
| Sponsor/Collaborators: |
Sponsor: State University of New York at Buffalo | Collaborators: American Diabetes Association
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
5
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-06
|
| Completion Date: |
2013-12
|
| Results First Posted: |
2019-10-04
|
| Last Update Posted: |
2019-10-04
|
| Locations: |
Millard Fillmore Gates Hospital, Buffalo, New York, 14209, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01155518
|
